Thrombocytopenia Global Clinical Trials Review, H1, 2015

Date: June 30, 2015
Pages: 110
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: TE3ABC020CAEN
Leaflet:

Download PDF Leaflet

Thrombocytopenia Global Clinical Trials Review, H1, 2015
Thrombocytopenia Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Thrombocytopenia Global Clinical Trials Review, H1, 2015' provides an overview of Thrombocytopenia clinical trials scenario. This report provides top line data relating to the clinical trials on Thrombocytopenia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Introduction
Thrombocytopenia
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Thrombocytopenia
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Thrombocytopenia Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Thrombocytopenia
Jun 12, 2015: FDA Approves Promacta for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
Jun 10, 2015: CTI BioPharma And Baxter Announce Patient-Reported Outcomes (PROs) From Pacritinib Phase 3 In Patients With Myelofibrosis To Be Presented In Late-Breaking Session At EHA
May 27, 2015: Amgen To present data from Nplate study at the 20th Congress of the EHA
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline Plc
Clinical Trial Overview of GlaxoSmithKline Plc
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Eisai Co., Ltd.
Clinical Trial Overview of Eisai Co., Ltd.
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Shionogi & Co., Ltd.
Clinical Trial Overview of Shionogi & Co., Ltd.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Octapharma AG
Clinical Trial Overview of Octapharma AG
Baxter International Inc.
Clinical Trial Overview of Baxter International Inc.
Rigel Pharmaceuticals, Inc.
Clinical Trial Overview of Rigel Pharmaceuticals, Inc.
Biogen, Inc.
Clinical Trial Overview of Biogen, Inc.
Clinical Trial Overview of Top Institutes / Government
Shandong University
Clinical Trial Overview of Shandong University
Weill Cornell Medical College
Clinical Trial Overview of Weill Cornell Medical College
Henri Mondor University Hospital
Clinical Trial Overview of Henri Mondor University Hospital
National Heart, Lung, and Blood Institute
Clinical Trial Overview of National Heart, Lung, and Blood Institute
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
Boston Children's Hospital
Clinical Trial Overview of Boston Children's Hospital
Hospital Universitario 'Dr. Jose E. Gonzalez'
Clinical Trial Overview of Hospital Universitario 'Dr. Jose E. Gonzalez'
New England Research Institutes
Clinical Trial Overview of New England Research Institutes
Peking University People's Hospital
Clinical Trial Overview of Peking University People's Hospital
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Thrombocytopenia Therapeutics, Global, Clinical Trials by Region, 2015*
Thrombocytopenia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
Thrombocytopenia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
Thrombocytopenia Therapeutics Clinical Trials, North America, Top Countries, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials, G7 Countries (%), 2015*
Thrombocytopenia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
Thrombocytopenia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials, E7 Countries (%), 2015*
Thrombocytopenia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
Thrombocytopenia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
Thrombocytopenia Therapeutics, Global, Clinical Trials by Phase, 2015*
Thrombocytopenia Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
Thrombocytopenia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
Thrombocytopenia Therapeutics, Global, Suspended Clinical Trials, 2015*
Thrombocytopenia Therapeutics, Global, Withdrawn Clinical Trials, 2015*
Thrombocytopenia Therapeutics, Global, Terminated Clinical Trials, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi & Co., Ltd., 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigel Pharmaceuticals, Inc., 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen, Inc., 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shandong University, 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Henri Mondor University Hospital, 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario 'Dr. Jose E. Gonzalez', 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by New England Research Institutes, 2015*
Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Peking University People's Hospital, 2015*

LIST OF FIGURES

Thrombocytopenia Therapeutics, Global, Clinical Trials by Region (%), 2015*
Thrombocytopenia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
Thrombocytopenia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
Thrombocytopenia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
Thrombocytopenia Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
Thrombocytopenia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
Thrombocytopenia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials, G7 Countries (%), 2015*
Thrombocytopenia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
Thrombocytopenia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials, E7 Countries (%), 2015*
Thrombocytopenia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
Thrombocytopenia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
Thrombocytopenia Therapeutics, Global, Clinical Trials by Phase (%), 2015*
Thrombocytopenia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
Thrombocytopenia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
Thrombocytopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
Thrombocytopenia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
GlobalData Methodology
Skip to top


Ask Your Question

Thrombocytopenia Global Clinical Trials Review, H1, 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: